Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sunlon Pharmaceutical, officially known as Sunlon (Beijing) Pharmaceutical Technology Co., Ltd., is a contract research organization (CRO) and biotechnology company based in Beijing, China. Founded in 2004, the company specializes in small molecule drug discovery and development services, including medicinal chemistry, custom synthesis, and process research and development. Sunlon provides technical support to global pharmaceutical and biotech partners, focusing on the design and synthesis of complex organic molecules and lead optimization. The company's expertise spans multiple therapeutic areas such as oncology, metabolic disorders, and cardiovascular diseases. By integrating chemical synthesis with biological evaluation, Sunlon aims to accelerate the transition of drug candidates from the laboratory to clinical stages.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sunlon Pharmaceutical.